The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Middle East and Africa Veterinary Vaccines Market Segmented By Animal Type, Technology and By Country - Industry Analysis, Market Size, Extensive Company Shares, Growth Trends and Y-O-Y Forecasts (2016-2021)

Middle East and Africa Veterinary Vaccines Market Segmented By Animal Type, Technology and By Country - Industry Analysis, Market Size, Extensive Company Shares, Growth Trends and Y-O-Y Forecasts (2016-2021)

Publishing Date : Jan, 2017

License Type :
 

Report Code : 429447

No of Pages : 165

Synopsis
The Middle-East & Africa animal vaccines market is poised to reach $541.4 Million by 2021 from $389.6 Million in 2016, at a CAGR of 6.8% from 2016 to 2021. Veterinary Vaccines are important and, at times, essential tools for prevention or control of a given animal disease, but they require complementary actions like enabling legislation, investment for diagnostic, early response, public communication etc.
The growing demand for livestock products (fuelled by population growth, increased urbanisation and greater purchasing power of individuals in developing or middle- income countries) coupled with the necessity of complying with the standards of trade agreements, mean that governments in the Middle-East & Africa region must improve animal health in their countries.
Veterinary vaccine market has shown significant growth in recent years which can be attributed to increasing incidences of animal pandemics in the region. Zoonoses like Anthrax, Salmonellosis(NTS) are the major diseases effecting this region. Other factors like Impact of Animal movement and role of organizations like GALVmed govern the market in this region. However, Scarcity of Arable Land and water, Ill effects of attenuated mutations and comparatively less return of investments constrain the growth of the market.
The Middle-East & Africa veterinary vaccines market has been categorized as livestock and companion vaccines. The livestock vaccines segment has been further segmented into five categories namely, bovine, porcine, ovine, poultry and equine. The companion animal vaccines segment has also been further categorized into feline and canine vaccines. In addition, based on production technologies the market is segmented as live attenuated vaccines, inactivated vaccines, toxoid vaccines and subunit vaccines. Furthermore, on the basis of geography, the Middle-East & Africa Market is analysed under major regions of Middle-East and Africa like South Africa, Nigeria, Israel, Saudi Arabia etc.
Some of the key players influencing the market are MSD Animal Health, Boehringer Ingelheim GmbH, Zoetis Inc., Merial S.A.S., Elanco Animal Health, Ceva Sante Animale, Hester Biosciences Ltd., Heska Corp., Onderstepoort Biological Products and JOVAC.

Geographical Area
Saudi Arabia, Israel, Iran, United Arab Emirates, Jordan, South Africa, Morocco, Kenya, Egypt, Uganda, Algeria, Namibia, Ethiopia.
Index
1 INTRODUCTION
1.1 MARKET DEFINITION
1.2 KEY DELIVERABLES OF THE STUDY
1.3 BASE CURRENCY, BASE YEAR, AND FORECAST PERIOD
1.4 GENERAL STUDY ASSUMPTIONS
2 RESEARCH APPROACH AND METHODOLOGY
2.1 INTRODUCTION
2.1.1 SIZE ESTIMATION
2.1.2 FORECASTING METHODOLOGY
2.2 RESEARCH PHASES
2.2.1 SECONDARY RESEARCH
2.2.2 PRIMARY RESEARCH
2.2.3 ECONOMETRIC MODELLING
2.2.4 EXPERT VALIDATION
2.3 ANALYSIS DESIGN
2.4 STUDY TIMELINE
3 OVERVIEW
3.1 EXECUTIVE SUMMARY
3.2 KEY INFERENCES
4 MARKET DYNAMICS
4.1 MARKET DRIVERS
4.1.1 GROWING DEMAND FOR LIVESTOCK PRODUCTS
4.1.2 INCREASING ZOONOTIC DISEASES
4.1.3 ADOPTION OF COMPANION ANIMALS
4.1.4 IMPACT OF ANIMAL MOVEMENT
4.1.5 GROWING REACH OF GALVMED
4.2 MARKET RESTRAINTS
4.2.1 SCARCITY OF ARABLE LAND AND WATER
4.2.2 LESS ATTRACTIVEFOR INVESTMENTS
4.2.3 ILL EFFECTS OF ATTENUATED MUTATIONS
4.2.4 VETERINARY PUBLIC HEALTH AND FOOD SAFETY
4.3 MARKET OPPORTUNITIES
4.3.1 INTERNATIONAL PARTNERSHIPS
4.3.2 INTERCONTINENTAL COLLABORATIONS
4.3.3 INNOVATIVE TECHNOLOGY
4.4 MARKET CHALLENGES
4.4.1 FLAWS IN RURAL VETERINARY SERVICES DELIVERY
4.4.2 FEAR OF COMPROMISE IN INTERNATIONAL TRADE
4.4.3 LIMITATIONS OF LIVE VACCINES
4.4.4 COMPETITION FOR RESOURCES
5 MARKET SEGMENTATION
5.1 MEA VETERINARY VACCINES MARKET, BY TYPE
5.1.1 INTRODUCTION
5.1.2 MEA LIVESTOCK ANIMAL VACCINES MARKET, BY TYPE
5.1.2.1. INTRODUCTION
5.1.2.2. BOVINE VACCINES
5.1.2.3. PORCINE VACCINES
5.1.2.4. POULTRY VACCINES
5.1.2.5. SHEEP AND GOAT VACCINES
5.1.2.6. EQUINE VACCINES
5.1.2.7. OTHER LIVESTOCK ANIMAL VACCINES
5.1.3 MEA COMPANION ANIMAL VACCINES MARKET, BY TYPE
5.1.3.1. INTRODUCTION
5.1.3.2. CANINE VACCINES
5.1.3.3. FELINE VACCINES
5.1.3.4. OTHER COMPANION ANIMAL VACCINES
5.2 MEA VETERINARY VACCINES MARKET, BY TECHNOLOGY
5.2.1.1. INTRODUCTION
5.2.1.2. LIVE/ATTENUATED VACCINES
5.2.1.3. INACTIVATED VACCINES
5.2.1.4. TOXOID VACCINES
5.2.1.5. SUBUNIT VACCINES
6 GEOGRAPHICAL ANALYSIS
6.1 MIDDLE EAST
6.1.1 SAUDI ARABIA
6.1.2 ISRAEL
6.1.3 IRAN
6.1.4 UNITED ARAB EMIRATES
6.1.5 JORDAN
6.2 AFRICA
6.2.1 SOUTH AFRICA
6.2.2 MOROCCO
6.2.3 KENYA
6.2.4 EGYPT
6.2.5 UGANDA
6.2.6 ALGERIA
6.2.7 NAMIBIA
6.2.8 ETHIOPIA
7 STRATEGIC ANALYSES
7.1 PESTLE ANALYSIS
7.1.1 POLITICAL
7.1.2 ECONOMICAL
7.1.3 SOCIAL
7.1.4 TECHNOLOGICAL
7.1.5 LEGAL
7.1.6 ENVIRONMENTAL
7.2 PORTER’S FIVE FORCES ANALYSES
7.2.1 THREAT OF NEW ENTRANTS
7.2.2 THREAT OF SUBSTITUTES
7.2.3 BARGAINING POWER OF SUPPLIERS
7.2.4 BARGAINING POWER OF BUYERS
7.2.5 INDUSTRY RIVALRY
8 COMPANY PROFILES
8.1 MSD ANIMAL HEALTH
8.1.1 OVERVIEW
8.1.2 PRODUCT ANALYSIS
8.1.3 FINANCIALS
8.1.4 RECENT DEVELOPMENTS
8.1.5 SWOT ANALYSIS
8.1.6 ANALYST OUTLOOK
8.2 BOEHRINGER INGELHEIM GMBH
8.2.1 OVERVIEW
8.2.2 PRODUCT ANALYSIS
8.2.3 FINANCIALS
8.2.4 RECENT DEVELOPMENTS
8.2.5 SWOT ANALYSIS
8.2.6 ANALYST OUTLOOK
8.3 ZOETIS INC.
8.3.1 OVERVIEW
8.3.2 PRODUCT ANALYSIS
8.3.3 FINANCIALS
8.3.4 RECENT DEVELOPMENTS
8.3.5 SWOT ANALYSIS
8.3.6 ANALYST OUTLOOK
8.4 MERIAL S.A.S.
8.4.1 OVERVIEW
8.4.2 PRODUCT ANALYSIS
8.4.3 FINANCIALS
8.4.4 RECENT DEVELOPMENTS
8.4.5 SWOT ANALYSIS
8.4.6 ANALYST OUTLOOK
8.5 ELANCO ANIMAL HEALTH
8.5.1 OVERVIEW
8.5.2 PRODUCT ANALYSIS
8.5.3 FINANCIALS
8.5.4 RECENT DEVELOPMENTS
8.5.5 SWOT ANALYSIS
8.5.6 ANALYST OUTLOOK
8.6 CEVA SANTE ANIMALE S.A.
8.6.1 OVERVIEW
8.6.2 PRODUCT ANALYSIS
8.6.3 FINANCIALS
8.6.4 RECENT DEVELOPMENTS
8.6.5 ANALYST OUTLOOK

8.7 HESTER BIOSCIENCES LIMITED
8.7.1 OVERVIEW
8.7.2 PRODUCT ANALYSIS
8.7.3 FINANCIALS
8.7.4 RECENT DEVELOPMENTS
8.7.5 SWOT ANALYSIS
8.7.6 ANALYST OUTLOOK
8.8 HESKA CORPORATION
8.8.1 OVERVIEW
8.8.2 PRODUCT ANALYSIS
8.8.3 FINANCIALS
8.8.4 RECENT DEVELOPMENTS
8.8.5 SWOT ANALYSIS
8.8.6 ANALYST OUTLOOK
8.9 ONDERSTEPOORT BIOLOGICAL PRODUCTS LTD (OBP)
8.9.1 OVERVIEW
8.9.2 PRODUCT ANALYSIS
8.9.3 FINANCIALS
8.9.4 ANALYST OUTLOOK
8.1 JOVAC
8.10.1 OVERVIEW
8.10.2 PRODUCT ANALYSIS
8.10.3 ANALYST OUTLOOK
9 COMPETITIVE LANDSCAPE
9.1 COMPANY SHARE ANALYSIS
9.2 MERGERS AND ACQUISITIONS
9.3 AGREEMENTS, COLLABORATIONS AND JOINT VENTURES
9.4 NEW PRODUCT LAUNCHES
10 EXPERT OPINIONS
10.1 MARKET OUTLOOK
10.2 INVESTMENT OPPORTUNITIES

Published By : Market Data Forecast

Why ‘The Market Reports’